Home
|
Learning Center
|
中文版
Publications
Search Publications:
search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
other
Abstract 3539: Vitamin D/......Abstract A111: Distinct i
Abstract A098: A role for......Abstract 509: HER2 genomi
Abstract LB-080: Imprime ......Abstract 4990: Sequential
Abstract 4983: Aminoflavo......Abstract 1308: Enhanced a
Abstract 1278: Popdc prot......Abstract PR250
Abstract PR394......Abstract 4114: Blocking E
Abstract 4079: IL-6 promo......Abstract 3805: A novel an
Abstract 4707: Investigat......Abstract 4059: Molecular
Abstract 4664: Co-targeti......Abstract 3739: Efficacy o
Abstract 4039: Mimotope v......Abstract 3165: An evidenc
Abstract 3992: Allogeneic......Abstract 3100: Hsp90 inhi
Abstract 3946: Stratifica......Abstract 4498: RNA-Seq in
Abstract 3636: Improved c......Abstract 3050: Proteotoxi
Abstract 3892: Unique ple......Abstract 3581: How to dea
Abstract 3047: Sensitizat......Abstract 3682: Phosphoryl
Abstract 4593: Analysis o......Abstract 1213: Thymidine
Abstract 1645: Tumor-asso......Abstract 2628: Molecular
Abstract 2606: Chemo-prev......Abstract 2119: Acquired n
Abstract 1137: Mutation a......Abstract 2086: Noscapine
Abstract 1576: Insertiona......Abstract 1680: Targeting
Abstract 1672: Photodynam......Abstract 2340: PD-1 block
Abstract 1777: Prostate c......Abstract 1341: PRINT: A p
Abstract 2760: Does a sho......Abstract 1731: Overexpres
Abstract 2245: FDG PET qu......Abstract 1730: Cancer ste
Abstract 2254: Variations......Abstract LB-206: A bromod
Abstract 4886: PEGylated ......Abstracts of the Third In
Abstracts der 24. Jahrest......Abstract # 1733 The perio
Abstract # 1838 Are “Lark......Abstract B27: Kinetochore
Abstract A21: Epigenetic ......Abstract B035: CXCL8/CXCR
Abstract B038: Class IIa ......Abstract B007: Improved d
Abstract B016: Costimulat......Abstract 4751: Genetic su
Abstract 4186: Syngenomic......Abstract 4140: Secreted p
Abstract 3248: Over-expre......Abstract 4121: Chaperonin
Abstract 4748: Targeting ......Abstract 546: Impact of t
Abstract 4890: Preclinica......Abstract CT110: Phase II
Abstract 5014: Predictive......Abstract 5065: Role of Ep
Abstract 666: Apc restora......Abstract 3338: Pacritinib
Abstract 530: Location of......Abstract 595: Next-genera
Abstract 4964: The isolat......Abstract 605: Building be
Abstract 4281: Mitochondr......Abstract 4242: Rhodamine
Abstract 4900: Increased ......Abstract B26: Novel pro-h
Abstract A04: Targeting i......Abstract IA20: Challenges
Abstract B30: Establishme......Abstract and Commentaries
Abstracts From the Third ......Abstract P5-17-05: Local
Abstract P5-12-03: Preval......Abstract P4-10-12: Psycho
Abstract P1-10-21: Voice ......Abstract IA02: Precision
Abstract IA04: Functional......Abstract IA01: Immune che
Abstract IA07: Metabolic ......Abstract B48: Optical too
Abstract B56: Treatment-i......Abstract IA03: Antitumor
Abstract B169: Matrix met......Abstract A164: Geneticall
Abstract A104: Eradicatio......Abstract C84: An efficien
Abstract IA11: Understand......Abstract B07: Treatment o
Abstract A12: Microenviro......Abstracts from the 12th A
Abstracts From the Procee......Abstract B34: Tandem Mass
Abstract B26: Cell surfac......Abstract A50: Chemoimmuno
Abstract A54: Regulating ......Abstract IA13: Inhibiting
Abstract IA23: Hippo/YAP ......Abstract A59: Prognostic
Abstract A39: A role for ......Abstract P2-08-14: Valida
Abstract P2-09-19: The pe......Abstract P3-07-60: Impact
Abstract P1-07-01: Charac......Abstract P3-14-10: Phase
Abstract P1-16-05: MDV310......Abstract PR479
Abstract PR478......Abstract PR492
Abstract PR276......Abstract PR372
Abstract PR285......Abstract PR331
Abstract PR026......Abstract PR375
Abstract PR057......Abstracts of the 32nd Ann
Abstracts from the Decemb......Abstract B27: A phase I d
Abstract book of the XX C......Abstract IA28: PI3K and m
Abstract IA21: Combinatio......Abstracts From the 36th A
Abstraction in Fixpoint L......Abstract P1-13-06: Impact
Abstract P1-13-08: Real-w......Abstract P4-12-05: Indivi
Abstract P4-12-04: Clinic......Abstract P4-15-11: Advanc
Abstract P5-19-16: Effect......Abstract P4-04-09: Mesenc
Abstract P3-06-16: Thromb......Abstract P6-02-01: Identi
Abstract P4-11-39: Epithe......Abstract P4-04-28: Weight
Abstract P6-11-05: Tumor ......Abstract A38: Optimizatio
Abstract A44: S100A4 driv......Abstract 74
Abstract 39......Abstract P13
Abstract P11......Abstract P90
Abstract P89......Abstract A17: The role of
Abstract A14: Overcoming ......Abstract PR07: Agonistic
Abstract B36: mRNA and de......Abstract C81: Identificat
Abstract C36: Patient-der......Abstract LB-B08: Somatic
Abstract LB-B18: Epitheli......Abstract A151: Quantitati
Abstract A106: Mechanisms......Abstract A53: Outcomes an
Abstract A99: Imprime PGG......Abstract B60: Therapeutic
Abstract A89: Istiratumab......Abstract C105: DNA damage
Abstract B146: Preclinica......Abstract A11: Biophysical
Abstract A06: N-MYC regul......Abstract A1-60: Gene muta
Abstract A1-09: Functiona......Abstract 3843: Nrf2-keap1
Abstract 381: Circulating......Abstract 3724: Race/ethni
Abstract 3727: Influence ......Abstract 2214: Dynamic tr
Abstract 1750: Preclinica......Abstract 1544: Associatio
Abstract 2478: A mAb with......Abstract 1611: The FACT h
Abstract 3093: CDK4 ampli......Abstract 2649: Inhibition
Abstract 3167: CCL2 recru......Abstract 2686: In vivo ER
Abstract 2094: GSK-3 is a......Abstract 655: The next ge
Abstract 1267: The senesc......Abstract 886: Health beha
Abstract 4463: Riluzole e......Abstract 140: Oncogenic s
Abstract 1388A: Assessmen......Abstract 4909: Increased
Abstract 5369: Low aspara......Abstract SY44-03: Proteog
Abstract SY43-01: Stereoc......Abstract 1121: Analysis o
Abstract 109: Y chromosom......Abstract 4148: Tankyrase
Abstract 1218: A biologic......Abstract 2671: INCB050465
